| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |